久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Company Profile

Nanjing Dorra Pharmaceutical Technology Co.,Ltd.
Year Established : 2011
Total Number of Staff : 10-50
Main Competitive Advantages : Experienced R&D Staff,Production Capacity,Contract Manufacturing (CRO,CMO),Quality Service
  • Contact Person :
  • Fax:
Dorrapharma is engaged in R&D, manufacture and market of intermediates, API and formulation. The services supplied are included in material sourcing, route selection, process & analytical development, custom synthesis and etc. The API sites are approved by CFDA, PMDA, EU authorities and the total reactor capacity is 2,000,000L and the output is about 5,000 tons per year. The therapeutic areas cover anti-infection, anti-virus, digestive system, cardiovascular system and etc.
PharmaSources Customer Service